6533b870fe1ef96bd12cfd14
RESEARCH PRODUCT
The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials
François Xavier CatherineLionel PirothS. MahyPascal ChavanetFlorian MorettoMarielle BuissonArnaud Salmon-rousseauHervé DevilliersMichel DuongThomas RogierIsabelle EberlMaroua AbdallahouiMathieu BlotClémentine EstèveThibault Sixtsubject
0301 basic medicineMicrobiology (medical)2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030106 microbiologyNEWS2Communicable DiseasesArticle03 medical and health sciences0302 clinical medicineMedicineHumans030212 general & internal medicineIntensive care medicineUnfavourable eventAgedbusiness.industrySARS-CoV-2COVID-19Therapeutic trialCoronavirusHospitalizationInfectious DiseasesItalySARS-CoV2businessPredictiondescription
Highlights • There is a need for reliable tools to predict the evolution of hospitalized patients suffering from COVID-19 • The likelihood of unfavourable evolution for patients hospitalized for COVID-19 with a National • Early Warning Score 2 (NEWS2) below 7 at Day 7 of hospitalization is nearly non-existent • Such a score could thus be used to allow earlier discharge of the patients and as a judgement criterion in therapeutic trials
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-02-01 | The Journal of Infection |